SCHEMBL7368255

SCHEMBL7368255

CCCOc1ccccc1-c1ccc(C(=O)O)c(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
PDE5A O76074 14/20 0.46
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
GAA P10253 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
KMT2A Q03164 2/20 0.45
USP2 O75604 2/20 0.45
MEN1 O00255 1/20 0.45
PDE2A O00408 1/20 0.45
PDE6D O43924 1/20 0.45
PDE9A O76083 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
PDE6A P16499 1/20 0.45
PDE6G P18545 1/20 0.45
PDE4A P27815 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149188 0.89 KMT2A (0.48) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A
SCHEMBL9370768 0.88 KDM4E (0.46) KDM4EPDE5AALDH1A1SMN1; SMN2GAA
SCHEMBL4066455 0.85 KDM4E (0.53) KDM4EALDH1A1SMN1; SMN2GAARXFP1
SCHEMBL9376126 0.84 PDE5A (0.45) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A
SCHEMBL7645372 0.82 KMT2A (0.53) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A
SCHEMBL9370220 0.80 PDE5A (0.47) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A
SCHEMBL9295923 0.80 PDE5A (0.57) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A
SCHEMBL7643686 0.79 PDE5A (0.45) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A
SCHEMBL9370740 0.79 PDE5A (0.44) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A
SCHEMBL7365111 0.79 PDE5A (0.46) KDM4EPDE5AALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347027-B1 Phenylpyridone derivatives,processes for their preparation and pharmaceutical compositions containing them. SMITH KLINE FRENCH LAB (GB) 1994-08-03 EP claimed
EP-0347027-A2 Phenylpyridone derivatives,processes for their preparation and pharmaceutical compositions containing them. SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP claimed
US-6479520-B1 REGULATING APOPTOSIS IN HUMAN CELLS WITH COMPOUNDS SUCH AS: 3-CYANO-6-(2-METHOXY-4-METHYLTHIOIPHENYL)-2(1H)-PYRIDINONE CELL PATHWAYS, INC. 2002-11-12 US disclosed
US-6046216-A USEFUL TO INHIBIT THE GROWTH OF NEOPLASTIC CELLS. CELL PATHWAYS, INC. (US) 2000-04-04 US disclosed
WO-1999059584-A1 COMBINATION OF PHENTOLAMINE AND CYCLIC GMP PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION SCHERING CORPORATION (US) 1999-11-25 WO disclosed
EP-0347027-B1 Phenylpyridone derivatives,processes for their preparation and pharmaceutical compositions containing them. SMITH KLINE FRENCH LAB (GB) 1994-08-03 EP disclosed
US-5254571-A Bronchodilators, antiallergens SMITH KLINE & FRENCH LABORATORIES LTD. (GB) 1993-10-19 US disclosed
EP-0347027-A2 Phenylpyridone derivatives,processes for their preparation and pharmaceutical compositions containing them. SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP disclosed